碳青霉烯耐药肺炎克雷伯菌检测和治疗研究进展  

Research progress on determination and treatment of carbapenem-resistant Klebsiella pneumoniae

作　　者：孙苗丽 吴琼[1] 王颖智[1] 王坚镪[1] 高锋[1] 汤瑾[1] SUN Miaoli;WU Qiong;WANG Yingzhi;WANG Jianqiang;GAO Feng;TANG Jin(Department of Clinical Laboratory,the Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine,Shanghai 200233,China)

机构地区：[1]上海交通大学医学院附属第六人民医院检验科,上海200233

出　　处：《检验医学》2024年第6期615-620,共6页Laboratory Medicine

摘　　要：近年来,碳青霉烯耐药肺炎克雷伯菌(CRKP)的检出率不断上升。CRKP耐药性强、散播迅速,感染患者病死率高,给临床治疗带来了巨大的挑战。目前,CRKP的检测方法主要包括碳青霉烯灭活法(CIM)、Carba NP试验、质谱技术、酶免疫分析法和分子检测技术。临床主要采用抗菌药物、噬菌体联合抗菌药物、疫苗和单克隆抗体等方法进行治疗。文章就CRKP检测和治疗方法的相关研究进展进行介绍,旨在为临床抗感染治疗提供新的思路。With the increasing determination rate of carbapenem-resistant Klebsiella pneumoniae(CRKP),strong CRKP drug resistance,rapid dissemination and high patients'mortality have brought challenges to clinical treatment.At present,the determination methods of CRKP mainly include carbapenem inactivation method(CIM),Carba NP test,mass spectrometry,enzymic immunochromatography and molecular determination technology.Antibiotic therapy,bacteriophage combined with antibiotics,vaccines and monoclonal antibodies are the main methods to treat CRKP.

关 键 词：碳青霉烯耐药 肺炎克雷伯菌 检测 治疗 

分 类 号：R378.99[医药卫生—病原生物学]